Core Viewpoint - Lamb Weston Holdings, Inc. is expected to report a decline in both revenue and earnings for the third quarter of fiscal 2026, with revenues projected at $1.48 billion, reflecting a 2.4% decrease year-over-year, and earnings per share estimated at 61 cents, indicating a 44.6% drop from the previous year [1][2][11] Revenue and Earnings Estimates - The Zacks Consensus Estimate for revenues is set at $1.48 billion, which represents a 2.4% decline from the same quarter last year [1][11] - The consensus estimate for earnings has decreased by 2 cents to 61 cents per share, marking a significant 44.6% reduction compared to the prior-year quarter [2][11] Factors Influencing Performance - Lamb Weston is likely experiencing continued pressure from unfavorable price/mix dynamics, with a projected 5.6% decline in price/mix for the third quarter [3] - Net sales in the North America and International segments are expected to decline by 1.2% and 4% year-over-year, respectively [4] - Margins are anticipated to remain under pressure due to higher manufacturing costs, particularly from the Argentina facility and underutilization in Europe, along with ongoing cost inflation across labor, transportation, and utilities [5] Positive Aspects - Despite the challenges, Lamb Weston is expected to benefit from volume momentum driven by customer wins and strong demand in North America [6] - Cost-saving initiatives are likely to provide some support, along with improving operational efficiencies and stable demand trends [6] Earnings Prediction - The model indicates a potential earnings beat for Lamb Weston, supported by a positive Earnings ESP of +6.90% and a Zacks Rank of 3 (Hold) [7]

Core Viewpoint - Levi Strauss & Co is expected to report a modest earnings beat for Q1 2026, but limited potential for significant market reaction is anticipated [2][3] Financial Performance - Analysts predict a first quarter EPS beat of $0.01 to $0.02, with fiscal 2026 EPS guidance likely reaffirmed at $1.40 to $1.46 per share [5][3] - Second quarter EPS guidance is expected to be in the range of $0.22 to $0.24 [5] Market Trends - Recent data indicates solid consumer trends, with US direct-to-consumer sales growing approximately 2% year-over-year in Q1, reflecting a ~420-basis-point acceleration from the previous quarter [6] - Website traffic increased by 8% in the US and 11% across key European sites, while US Google searches for the brand rose by 13% year-over-year [6] Investor Sentiment - Despite positive operational trends, investor sentiment has softened, with shares down nearly 13% over the past three months, compared to a roughly 5% decline in the S&P 500 [7] - Short interest has climbed to 12.9%, indicating a slightly bearish sentiment among investors [7] Valuation - UBS maintains a Buy rating with a price target of $33, based on approximately 17 times projected fiscal 2028 EPS of $1.95 [8] - The positive outlook is supported by strong brand fundamentals, controlled promotional activity, and peer-aligned valuation metrics [8]

Core Viewpoint - Chewy Inc. reported fourth-quarter results that significantly exceeded earnings expectations, leading to a 13% increase in share price intra-day [1] Financial Performance - The company posted adjusted earnings per share of $0.27, surpassing the analyst consensus of $0.09 by $0.18 [2] - Revenue reached $3.26 billion, aligning with estimates and representing an 8.1% increase on a normalized 13-week basis compared to the prior year period; on a reported basis, revenue rose 0.5% year over year due to the quarter having 13 weeks versus 14 weeks in the prior year [2] - Gross margin expanded by 90 basis points year over year to 29.4%, while adjusted EBITDA margin improved by 120 basis points to 5.0% [3] - Adjusted EBITDA totaled $162.3 million, increasing by $37.8 million compared to the prior year [3] - For the full fiscal year 2025, Chewy reported net sales of $12.60 billion, reflecting an 8.3% increase on a normalized 52-week basis [3] - Adjusted EBITDA rose to $719.2 million, up $148.7 million year over year, with adjusted EBITDA margin expanding 90 basis points to 5.7% [3] - The company generated record free cash flow of $562 million during the year [4]

Core Insights - Chewy, Inc. (CHWY) is expected to report a 0.3% increase in quarterly sales, with the Zacks Consensus Estimate at $3.3 billion for the fourth quarter of fiscal 2025 [1] - The earnings consensus for the same quarter remains stable at 28 cents per share, comparable to the previous year's figure [1] Group 1: Performance and Growth Factors - Chewy has delivered an average earnings surprise of 10.7% over the last four quarters, with a 6.7% surprise in the last reported quarter [2] - The company's performance is likely to benefit from digital capabilities, product assortments, and expansion efforts, including technology upgrades to drive sales [3] - The resilience in the pet category and the strength of Chewy's value proposition are seen as positive factors [3] - Chewy's expansion into pet healthcare and high-margin services has been encouraging [3] Group 2: Revenue and Customer Engagement Strategies - The Autoship program is providing predictable revenues and improving customer retention, while Chewy+ is designed to increase order frequency and customer spending [4] - Chewy emphasizes data-driven marketing and a mobile-first strategy to enhance customer acquisition and retention, leveraging advanced analytics and improved app functionality [5] - The Zacks Consensus Estimate for net sales per active customer is $593, reflecting a 2.6% increase from the previous year [6] Group 3: Challenges and Market Conditions - A tough operating environment, subdued industry demand, and increased promotional activity may pose challenges to Chewy's performance [7] - Potential moderation in customer additions could limit near-term operating leverage [7] Group 4: Earnings Prediction - The Zacks model predicts an earnings beat for Chewy, supported by a positive Earnings ESP of +7.14% and a Zacks Rank of 3 [8]

Core Viewpoint - Best Buy Co Inc (NYSE:BBY) shares are experiencing upward momentum following a strong earnings report, which has attracted renewed analyst coverage [1] Earnings Performance - Best Buy reported fourth-quarter earnings of $2.61 per share, exceeding expectations of $2.47 by a significant margin [2] - Revenue for the quarter was $13.81 billion, slightly below the estimated $13.88 billion, and down $134 million compared to the previous year [2] - The company provided fiscal 2027 earnings guidance of $6.30 to $6.60 per share, which is slightly below consensus, but included several initiatives to reassure investors [2] Analyst Insights - Piper Sandler noted the growth in Best Buy's advertising and marketplace businesses, which are expected to contribute to steady margins [3] - Analysts highlighted that Best Buy is actively managing rising memory-chip costs, with the midpoint of the company's guidance assuming only a moderate impact from these higher component prices [3] Analyst Ratings and Price Targets - Financial analysts maintain a steady outlook for Best Buy, with most recent ratings holding firm [4] - Citigroup maintained a neutral rating and raised its price target from $67.00 to $69.00 [4] - Evercore ISI Group kept an in-line rating, increasing its target from $70.00 to $75.00 [4] - Goldman Sachs maintained a buy rating but reduced its target from $93.00 to $76.00 [4] Additional Analyst Actions - BNP Paribas retained its neutral stance and increased its target from $68.00 to $74.00 [5] - Morgan Stanley maintained an equal-weight rating but lowered their target price from $76.00 to $72.00, indicating a more cautious outlook [5] - At the time of publication, Best Buy shares were up 2.21% at $67.41 [5]

Core Viewpoint - CrowdStrike Holdings reported better-than-expected earnings, leading to a rise in its stock price [1] Company Performance - The earnings report was released after the stock market closed on Tuesday [1] - CrowdStrike has faced challenges this year, similar to other business-software companies [1]

Core Insights - Best Buy Co., Inc. reported fourth-quarter earnings that exceeded analyst expectations, with adjusted earnings per share at $2.61, surpassing the consensus estimate of $2.47 by $0.14 [1] - The company's revenue totaled $13.81 billion, slightly below the forecast of $13.91 billion and down 1% from $13.95 billion in the prior-year quarter, with comparable sales declining by 0.8% [1] Fiscal 2027 Guidance - For fiscal 2027, Best Buy guided adjusted EPS between $6.30 and $6.60, with a midpoint of $6.45, which is below the consensus estimate of $6.65 [2] - Revenue is expected to range from $41.2 billion to $42.1 billion, with a midpoint of $41.65 billion, also below the consensus of $42.2 billion [2] - The company projected approximately 1% comparable sales growth for the first quarter and an adjusted operating income rate of roughly 3.9% [2] Domestic Segment Performance - The domestic segment generated revenue of $12.58 billion, down 1.1% year over year, with declines in home theater and appliances partially offset by growth in computing and mobile phones [3] - The domestic gross profit rate remained steady at 20.9%, as expansion in Best Buy Ads and Marketplace helped offset lower product margins [3] Fiscal 2026 Performance - For fiscal 2026, Best Buy returned to positive comparable sales growth of 0.5% and expanded its operating income rate [4] - The board approved a 1% increase in the dividend to $0.96 per share, payable on April 14, 2026 [4]

Core Insights - PRA Group, Inc. (PRAA) is scheduled to report its fourth-quarter 2025 results on February 26, 2026, with earnings expected at 50 cents per share and revenues at $304.18 million [1] Financial Performance Estimates - The fourth-quarter earnings estimate has remained stable over the past 60 days, indicating a year-over-year growth of 6.4% for earnings and a 3.7% increase for revenues [2] - For the full year 2025, the revenue estimate for PRA Group is $1.17 billion, reflecting a 5.2% year-over-year rise, while the EPS estimate is $1.45, indicating a decline of 19% year-over-year [3] Earnings Prediction Factors - The current model does not predict an earnings beat for PRA Group, as it has an Earnings ESP of 0.00% and a Zacks Rank of 3 (Hold) [4] - Factors expected to influence Q4 results include a 10.4% increase in cash collections and a 14.3% rise in portfolio income, although higher legal and operating costs may limit earnings upside [7][10] Cash Collections and Portfolio Income - Improved cash collections and disciplined purchasing activity are anticipated to benefit PRA Group, with total cash collections expected to grow by 10.4% year-over-year [8] - The consensus estimate for fourth-quarter portfolio income is $262.5 million, representing a 14.3% increase from the previous year [9] Operating Expenses and Recovery Estimates - The consensus mark for expected recoveries is currently at $35 million, down 36.7% year-over-year, and other revenues are pegged at $3.1 million, down 62.6% from a year ago [10] - Total operating expenses are likely to have increased due to higher legal collection costs and other operational expenses, making an earnings beat uncertain [10]

Core Insights - Medline Inc. (MDLN) is set to report its fourth-quarter 2025 results on February 25, marking its first earnings report as a publicly traded company after its debut on December 17, 2025 [1][9] Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, operating through its Medline Brand and Supply Chain Solutions segments, offering approximately 335,000 products [2] - The company serves various healthcare facilities, including hospitals and ambulatory surgery centers, through a logistics network comprising 69 global distribution centers and a dedicated fleet for next-day delivery to most U.S. customers [3] Q4 Estimates - The Zacks Consensus Estimate for Medline's revenues is $7.52 billion, with earnings expected to be 24 cents per share [4][9] Factors to Consider Before Earnings Report - Investors will focus on the performance mix between Medline's two segments, particularly the Prime Vendor strategy, which aims to enhance procurement efficiency and increase the penetration of higher-margin Medline Brand products [5] - Customer conversion trends and the evolution of product mix are critical, as the Medline Brand is the company's profitability engine, supported by exclusive supplier relationships and a diversified product range [6] - Broader healthcare utilization trends, such as an aging population and rising chronic disease prevalence, are expected to support steady demand for medical-surgical products, with Medline's distribution capabilities likely influencing investor confidence [7] Earnings Prediction Insights - The current model does not predict an earnings beat for MDLN, as the Earnings ESP is 0.00% and the company holds a Zacks Rank of 3 (Hold) [8][10]

Core Insights - Home Depot reported better-than-expected earnings, with shares rising 3.4% following the announcement [1][3] - Lowe's also saw a positive response, with shares up over 2% [2] Earnings Performance - Home Depot's comparable sales and gross margins exceeded expectations, leading to an earnings beat of approximately $0.20 above forecasts [3] - Despite the earnings beat, sales showed a slight decline, attributed to insufficient weather-related demand [4] Future Outlook - The company maintains its guidance for 0-2% growth in comparable sales for the year, indicating a cautious outlook [5] - Operating margins are expected to remain flat through 2026, with modest increases in earnings per share anticipated [6][10] - There is a lack of significant consumer interest in housing turnover, which is crucial for driving sales in the home improvement sector [6][10] Market Conditions - The current housing market shows marginal improvement, but not enough to significantly boost sales for Home Depot [5][7] - The impact of weather patterns and tariffs on sales remains a concern, with the company noting underperformance in categories typically driven by weather [7][8] Analyst Ratings - Morning Star downgraded Home Depot's rating from three stars to two stars, with a price target reduced from $345 to $325 [8] - The downgrade reflects concerns over flat operating margins and limited earnings growth potential, leading to a cautious investment outlook [10] Competitive Landscape - Comparisons with Lowe's suggest that consumer behavior may differ, particularly regarding smaller projects that Lowe's Pro targets [12] - Both companies face challenges due to evolving tariff situations, which complicate consumer spending decisions [13]